Cargando…

NT5DC2 is a novel prognostic marker in human hepatocellular carcinoma

Reliable biomarkers for the prognosis of hepatocellular carcinoma (HCC) are rare, and novel biomarkers are required for the appropriate management of HCC. 5′-Nucleotidase domain containing 2 (NT5DC2) acts as an oncogene in various tumors, but its functions as a biomarker have not been confirmed. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jiemin, Cao, Jianzhong, Wang, Penghui, He, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436888/ https://www.ncbi.nlm.nih.gov/pubmed/32863903 http://dx.doi.org/10.3892/ol.2020.11931

Ejemplares similares

Systemic characterization of the SLC family genes reveals SLC26A6 as a novel oncogene in hepatocellular carcinoma
por: Cao, Jianzhong, et al.
Publicado: (2021)

Comprehensive Analysis of Prognostic Value and Immune Infiltration of the NT5DC Family in Hepatocellular Carcinoma
por: Li, Rongqi, et al.
Publicado: (2022)

NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma
por: Li, Kang-Shuai, et al.
Publicado: (2020)

High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma
por: Schulze, Arik Bernard, et al.
Publicado: (2022)

The NT5DC family: expression profile and prognostic value in pancreatic adenocarcinoma
por: Yu, Xiaoqian, et al.
Publicado: (2023)

Comprehensive analysis of NT5DC family prognostic and immune significance in breast cancer
por: Jia, Yiwei, et al.
Publicado: (2023)

Serum AFU, 5’-NT and AFP as Biomarkers for Primary Hepatocellular Carcinoma Diagnosis
por: Junna, Zhu, et al.
Publicado: (2017)

Gastric cancer metastasis-related NT5DC2 indicates unfavorable prognosis of patients
por: Sha, Rula, et al.
Publicado: (2023)

The Clinical Significance of DC-SIGN and DC-SIGNR, which Are Novel Markers Expressed in Human Colon Cancer
por: Jiang, Yanmei, et al.
Publicado: (2014)

CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma
por: Liu, Yanli, et al.
Publicado: (2022)

Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma
por: Liu, Fangming, et al.
Publicado: (2020)

Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma
por: Qiu, Jiliang, et al.
Publicado: (2011)

Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma
por: Liu, Weifeng, et al.
Publicado: (2017)

Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker
por: Zhang, Yaoting, et al.
Publicado: (2022)

Lrig1 is a positive prognostic marker in hepatocellular carcinoma
por: Yang, Bo, et al.
Publicado: (2016)

Heterogeneity characterization of hepatocellular carcinoma based on the sensitivity to 5-fluorouracil and development of a prognostic regression model
por: Gu, Xinyu, et al.
Publicado: (2023)

Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5′-nucleotidase (CD73)
por: Snider, Natasha T., et al.
Publicado: (2014)

Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy
por: Wang, Yifei, et al.
Publicado: (2019)

NLRC5, a valuable marker for the diagnosis and prognostic assessment of hepatocellular carcinoma
por: Zhang, Xiu-Wen, et al.
Publicado: (2020)

Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma
por: Mínguez, Beatriz, et al.
Publicado: (2011)

KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma
por: Li, Wen-Chao, et al.
Publicado: (2019)

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma
por: Liang, Hao, et al.
Publicado: (2021)

Thioredoxin reductase: A novel, independent prognostic marker in patients with hepatocellular carcinoma
por: Li, Chunyan, et al.
Publicado: (2015)

SAC3D1: a novel prognostic marker in hepatocellular carcinoma
por: Han, Myoung-Eun, et al.
Publicado: (2018)

LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma
por: Zhang, Hongbin, et al.
Publicado: (2020)

NT5E Mutations That Cause Human Disease Are Associated with Intracellular Mistrafficking of NT5E Protein
por: Fausther, Michel, et al.
Publicado: (2014)

Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes
por: Yan, Junbin, et al.
Publicado: (2021)

Correction: NT5E Mutations That Cause Human Disease Are Associated with Intracellular Mistrafficking of NT5E Protein
Publicado: (2015)

CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker
por: Shen, Zhiqing, et al.
Publicado: (2018)

Cellular prognostic markers in hepatitis-related hepatocellular carcinoma
por: Petrizzo, A., et al.
Publicado: (2018)

Prognostic value of inflammatory and nutritional markers for hepatocellular carcinoma
por: Xu, Yingying, et al.
Publicado: (2021)

RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma
por: Zheng, Wangyang, et al.
Publicado: (2022)

Comprehensive Analysis of HOX Family Members as Novel Diagnostic and Prognostic Markers for Hepatocellular Carcinoma
por: Jin, Zhipeng, et al.
Publicado: (2022)

Prognostic Value of Combined Aquaporin 3 and Aquaporin 5 Overexpression in Hepatocellular Carcinoma
por: Guo, Xiaodong, et al.
Publicado: (2013)

TPX2 Is a Prognostic Marker and Contributes to Growth and Metastasis of Human Hepatocellular Carcinoma
por: Huang, Yuqi, et al.
Publicado: (2014)

Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
por: Yamamoto, Masateru, et al.
Publicado: (2019)

Decreased DC-SIGNR expression in hepatocellular carcinoma predicts poor patient prognosis
por: Xia, Hai-Bing, et al.
Publicado: (2020)

S100 Proteins as Diagnostic and Prognostic Markers in Colorectal and Hepatocellular Carcinoma
por: Maletzki, Claudia, et al.
Publicado: (2012)

Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma
por: Yoneoka, Grant, et al.
Publicado: (2020)

TMEM206 is a potential prognostic marker of hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mmc65ehkn6fqofhne736tcvqvd